Privium Fund Management B.V. Voyager Therapeutics, Inc. Transaction History
Privium Fund Management B.V.
- $381 Million
- Q1 2025
A detailed history of Privium Fund Management B.V. transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Privium Fund Management B.V. holds 21,645 shares of VYGR stock, worth $63,203. This represents 0.02% of its overall portfolio holdings.
Number of Shares
21,645Holding current value
$63,203% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding VYGR
# of Institutions
121Shares Held
34.6MCall Options Held
12.9KPut Options Held
37.7K-
Armistice Capital, LLC New York, NY5.44MShares$15.9 Million0.28% of portfolio
-
Black Rock Inc. New York, NY5.31MShares$15.5 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$11.4 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$9.38 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.57MShares$7.51 Million0.05% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $113M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...